astrazeneca glp 1 drug CEO on GLP-1 Weight Loss Developments AstraZeneca's oral obesity drug Elecoglipron

Pharmacological basis and new insights of resveratrol action in the cardiovascular system

Even though edavarone seems to be of value in neurological disorders, it has limited ability to cross the BBB

Chem 63, 1246012484 [DOI] [PubMed] [Google Scholar] 90.Bondarev AD et al

Free radical-mediated oxidation of free amino acids and amino acid residues in proteins

In animal models, a hydroalcoholic extract of tribulus relieved cisplatin-induced renal toxicity, perhaps via diuretic effects that increase drug excretion, scavenging free radicals via increase in antioxidant enzymes, suppressing inflammatory agents, and acting on organic cation transporter 2 (OCT2) proteins (41)

Breaks down and reduces localized fat